1375108-40-9

Basic information

• Product Name: 7-BroMo-quinoline-3-carbonitrile
• Synonyms: 7-BroMo-quinoline-3-carbonitrile;7-methylquinoline-3-carbonitrile
• CAS NO: 1375108-40-9
• Molecular Formula: C10H5BrN2
• Molecular Weight: 233.0641
• Mol File: 1375108-40-9.mol
• Article Data: 6

Chemical Properties

• Boiling Point: 379.7±22.0 °C(Predicted)
• Appearance: /
• Density: 1.66±0.1 g/cm3(Predicted)
• Storage Temp.: Sealed in dry,Room Temperature
• PKA: 0.14±0.25(Predicted)
• CAS DataBase Reference: 7-BroMo-quinoline-3-carbonitrile(CAS DataBase Reference)
• NIST Chemistry Reference: 7-BroMo-quinoline-3-carbonitrile(1375108-40-9)
• EPA Substance Registry System: 7-BroMo-quinoline-3-carbonitrile(1375108-40-9)

Safety Data

• Hazardous Substances Data: 1375108-40-9(Hazardous Substances Data)

Usage

General Description

7-Bromo-quinoline-3-carbonitrile is a chemical compound with the molecular formula C10H5BrN2. It is a yellow crystalline solid with a molecular weight of 228.07 g/mol. This chemical is used as an intermediate in the synthesis of pharmaceuticals and agrochemicals. It is also known to possess antimicrobial and anticancer properties. 7-Bromo-quinoline-3-carbonitrile has the potential to be used in various research and industrial applications due to its unique chemical structure and properties. However, it is important to handle this compound with caution as it may pose health and environmental risks if not properly managed.

Upstream product

• 2032-34-0 3,3-bis(ethyloxy)propanenitrile 
• 59278-65-8 2-amino-4-bromobenzaldehyde 
• 288-14-2 ISOXAZOLE 

Downstream Products

• 1296950-66-7 7-bromoquinolin-3-carboxamide 

Relevant articles and documents

Ru(III)-catalyzed construction of variously substituted quinolines from 2-aminoaromatic aldehydes (ketones) and isoxazoles: Isoxazoles as cyclization reagent and cyano sources

A Ru(Ⅲ)-catalyzed annulation reaction of 2-aminoaromatic aldehydes (ketones) and isoxazoles to afford diverse 3-cyanoquinolines has been developed. Notably, isoxazole acted as a cyclization reagent and nontoxic cyano source via N-O bond cleavage and fragm

FATTY ACID SYNTHASE INHIBITORS

This invention relates to novel spirocyclic piperidines according to Formula (I) which are inhibitors of fatty acid synthase (FAS), to pharmaceutical compositions containing them, to processes for their preparation, and to their use in therapy for the treatment of cancers.

FATTY ACID SYNTHASE INHIBITORS

This invention relates to spirocyclic piperidines according to Formula (I) and the use of spirocyclic piperidines for the modulation, notably the inhibition of the activity or function of fatty acid synthase (FAS). Suitably, the present invention relates to the use of spirocyclic piperidines in the treatment of cancer.